On Jun. 2, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service confirmed the…
On May 31, 2022, Moderna and Takeda announced the transfer of the marketing authorization for Moderna’s COVID-19 vaccine…
On May 31, 2022, Novavax announced the initiation of its Phase 3 strain change trial to determine if…
On May 30, 2022, The Centre for Health Protection (CHP) of the Department of Health received notification from…
On May 25, 2022, Novavax announced it was participating in a stage of the COVID-19 Vaccine Schedule Combinations…
On May 25, 2022, Pfizer and BioNTech announced topline safety, immunogenicity and vaccine efficacy data from a Phase…
On May 25, 2022, Roche and its subsidiary TIB Molbiol announced they had developed three unique LightMix Modular…
On May 21, 2022, the World Health Organization (WHO) announced that since May 13, 2022, cases of mpox…
On May 20, 2022, Novavax announced the submission of a request to the European Medicines Agency (EMA) to…
On May 19, 2022, World Health Organization (WHO) issued an emergency use listing (EUL) for CONVIDECIA, a vaccine…
On May 18, 2022, researchers at Gladstone Institutes and UC San Francisco (UCSF) reported that unvaccinated people, infection…
On May 18, 2022, Moderna and the nonprofit scientific research organization IAVI announced that the first participant screenings…
On May 18, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On May 18, 2022, scientists at the Centers for Disease Control and Prevention (CDC) announced that they were…
On May 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration expanded emergency use authorization…
On May 13, 2022, Novavax announced the submission of a request for emergency use authorization to Taiwan’s Food…
On May 12, 2022, the World Health Organization (WHO) COVID-19 Technology Access Pool and the Medicines Patent Pool…
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
On May 6, 2022, Novavax announced that deliveries of it’s COVID-19 vaccine continued around the world and the…
On May 6, 2022, Novavax announced the submission of variations to the Australian Therapeutic Goods Agency (TGA) and…
On Apr. 29, 2022, Moderna announced its plan to build a state-of-the-art mRNA vaccine manufacturing facility in Quebec…
On Apr. 28, 2022, Moderna announced that it had submitted a request for emergency use authorization (EUA) for…
On Apr. 28, 2022, the Ministry of Health of the Democratic Republic of the Congo declared an outbreak…
On Apr. 28, 2022, Centers for Disease Control and Prevention (CDC) reported that a person had tested positive…
On Apr. 26, 2022, Pfizer and BioNTech submitted an application to the U.S. Food and Drug Administration (FDA)…
On Apr. 22, 2022, Novavax announced initial results from the Phase 1/2 clinical trial of its COVID-Influenza Combination…
On Apr. 20, 2022, Novavax announced initial results from the Phase 1/2 clinical trial of its COVID-Influenza Combination…
On Apr. 20, 2022, Codiak BioSciences announced announc a Non-Clinical Evaluation Agreement (NCEA) with the National Institute of…
On Apr. 19, 2022, Novavax announced that its partner, Takeda, received manufacturing and marketing approval from the Japan…
On Apr. 18, 2022, the Military Health System reported that active-duty service members who received a COVID-19 vaccine…